PlainRecalls
FDA Drug Critical Class I Terminated

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Reported: February 25, 2015 Initiated: October 6, 2014 #D-0389-2015

Product Description

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Reason for Recall

Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

Details

Recalling Firm
Hospira Inc.
Units Affected
2,500 vials
Distribution
Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribution was Nationwide for the Vancomycin 1 g product.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.. Recalled by Hospira Inc.. Units affected: 2,500 vials.
Why was this product recalled?
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 25, 2015. Severity: Critical. Recall number: D-0389-2015.